Nurse-led patient-centered self-management support improves HbA1c in patients with type 2 diabetes—A randomized study

Patient Education and Counseling

Volumn 99, Issue 11, 2016, Pages 1821-1829

  Jutterstrom L ^a   Hornsten A ^a   Sandstrom H ^a   Stenlund, H ^a   Isaksson, U ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

Intervention; Led by nurses; Patient centered; Self management support; Type 2 diabetes

Indexed keywords

CHOLESTEROL; HEMOGLOBIN A1C; ANTIDIABETIC AGENT; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DIET THERAPY; FEMALE; FOLLOW UP; HEALTH SERVICE; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; NURSE; PATIENT CENTERED SELF MANAGEMENT SUPPORT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING; THERAPY EFFECT; ATTITUDE TO HEALTH; DIABETES MELLITUS, TYPE 2; MANPOWER; METABOLISM; NURSE PATIENT RELATIONSHIP; NURSING; PATIENT CARE; PATIENT EDUCATION; PROCEDURES; SELF CARE; SWEDEN;

ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NURSE-PATIENT RELATIONS; PATIENT EDUCATION AS TOPIC; PATIENT-CENTERED CARE; SELF CARE; SWEDEN;

EID: 84977644562     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2016.06.016     Document Type: Article

References (50)

1. [1] Genuth, S., The UKPDS and its global impact. Diabet. Med. 25 (2008), 57–62.
2. [2] Inzucchi, S., Bergenstal, R., Buse, J., Diamant, M., Ferrannini, E., Nauck, M., Peters, A., Tsapas, A., Wender, R., Matthews, D., Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Acta Diabetol. 55 (2012), 1577–1596.
3. [3] Holman, R.R., Paul, S.K., Bethel, M.A., Matthews, D.R., Neil, H.A.W., 10-Year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 359 (2008), 1577–1589.
4. [4] Turnbull, F.M., Abraira, C., Anderson, R.J., Byington, R.P., Chalmers, J.P., Duckworth, W.C., Evans, G.B., Gerstein, H.C., Holman, R.R., Moritz, T.E., Neal, B.C., Ninomiya, T., Patel, A.A., Paul, S.K., Travert, F., Woodward, M., Intensive glucose control and macrovascular outcomes in type 2 diabetes. Acta Diabetol. 52 (2009), 2288–2298.
5. [5] Ismail-Beigi, F., Moghissi, E., Tiktin, M., Hirsch, B., Inzucchi, S.E., Genuth, S., Individualizing glycemic targets in type 2 diabetes mellitus: implication of recent clinical trials. Ann. Int. Med. 154 (2011), 554–559.
6. [6] IDF Clinical Guidelines Task Force, Global guidelines for type 2 diabetes. 2012, IDF Clinical Guidelines Task Force, 1–117 Available at http://www.idf.org/sites/default/files/IDF%20Guideline%20for%20Type%202%20Diabetes.pdf (accessed 23.09.15).
7. [7] Akalin, S., Berntorp, K., Ceriello, A., Das, A.K., Kilpatrick, E.S., Koblik, T., Munichoodappa, C.S., Pan, C.Y., Rosenthall, W., Shestakova, M., Wolnik, B., Woo, V., Yang, W.Y., Yilmaz, M.T., Intensive glucose therapy and clinical implications of recent data: a consensus statement from the gobal task force on glycaemic control. Int. J. Clin. Pract. 63 (2009), 1421–1425.
8. [8] Haas, L., Maryniuk, M., Beck, J., Cox, C.E., Duker, P., Edwards, L., Fisher, E.B., Hanson, L., Kent, D., Kolb, L., National standards for diabetes self-management education and support. Diabet. Care 36 (2013), S100–S800.
9. [9] Gudbjörnsdottir, S., Cederholm, J., Nilsson, P.M., Eliasson, B., The national diabetes register in Sweden. Diabet. Care 26 (2003), 1270–1276.
10. [10] Swedish National Board of Health and Welfare, Swedish Guidelines for Diabetes Care [In Swedish: Nationella riktlinjer för diabetesvården 2014: stöd för styrning och ledning]. 2014, Socialstyrelsen, Stockholm Available at: https://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/19470/2014-6-19.pdf (accessed 17.09.15).
11. [11] Adolfsson, E.T., Smide, B., Gregeby, E., Fernstrom, L., Wikblad, K., Implementing empowerment group education in diabetes. Patient Educ. Couns. 53 (2004), 319–324.
12. [12] Hörnsten, Å., Graneheim, U.H., A lesson to learn—patients’ critiques of diabetes nursing. J. Adv. Nurs., 11, 2009 http://ispub.com/IJANP/11/1/4278.
13. [13] Epstein, R.M., Fiscella, K., Lesser, C.S., Stange, K.C., Why the nation needs a policy push on patient-centered health care. Health Aff. 29 (2010), 1489–1495.
14. [14] Glasgow, R.E., Peeples, M., Skovlund, S.E., Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabet. Care 31 (2008), 1046–1050.
15. [15] Mead, N., Bower, P., Patient-centredness: a conceptual framework and review of the empirical literature. Soc. Sci. Med. 51 (2000), 1087–1110.
16. [16] Michie, S., Miles, J., Weinman, J., Patient-centredness in chronic illness: what is it and does it matter?. Patient Educ. Couns. 51 (2003), 197–206.
17. [17] Stewart, M., Brown, J.B., Donner, A., McWhinney, I.R., Oates, J., Weston, W.W., Jordan, J., The impact of patient-centered care on outcomes. J. Fam. Pract. 49 (2000), 796–804.
18. [18] Swedish Agency for Health and Care Services Analysis, Patient Centeredness in Sweden’ Health System—An External Assessment and Six Steps for Progress. 2012, Swedish Agency for Health and Care Services Analysis, 1–84 Available at http://www.vardanalys.se/Global/Rapporter%20pdffiler/2012/R3_2012_Patient_centeredes.pdf (accessed 23.08.15).
19. [19] International Alliance of Patients’ Organizations (IAPO), What is Patient-centered Health Care? A Review of Definitions and Principles. 2007, International Alliance of Patients’ Organizations (IAPO), 1–37 Available at: http://www.patientsorganizations.org/attach.pl/547/494/IAPO%20Patient-Centred%20Healthcare%20Review%202nd%20edition.pdf (accessed 23.08.15).
20. [20] Jutterström, L., Graneheim, U., Isaksson, U., Hörnsten, Å., Ideal versus real conditions for type 2 diabetes care: diabetes specialty nurses’ perspectives. Internet J. Adv. Nurs. Pract., 2012, 11, 10.5580/2a5f.
21. [21] Boström, E., Isaksson, U., Lundman, B., Lehuluante, A., Hörnsten, Å., Patient-centred care in type 2 diabetes—an altered professional role for diabetes specialist nurses. Scand. J. Caring Sci. 28 (2014), 675–682.
22. [22] Irwin, R.S., Richardson, N.D., Patient-focused care using the right tools. Chest 130 (2006), S73–S82.
23. [23] Norris, S.L., Engelgau, M.M., Venkat Narayan, K.M., Effectiveness of self-management training in type 2 diabetes. Diabet. Care 24 (2001), 561–587.
24. [24] Heisler, M., Piette, J.D., Spencer, M., Kieffer, E., Vijan, S., The relationship between knowledge of recent HbA1c values and diabetes care understanding and self-management. Diabet. Care 28 (2005), 816–822.
25. [25] Cochran, J., Conn, V.S., Meta-analysis of quality of life outcomes following diabetes self-management training. Diabet. Educ. 34 (2008), 815–823.
26. [26] Gary, T.L., Genkinger, J.M., Guallar, E., Peyrot, M., Brancati, F.L., Meta-analysis of randomized educational and behavioral interventions in type 2 diabetes. Diabet. Educ. 29 (2003), 488–501.
27. [27] Steed, L., Cooke, D., Newman, S.A., Systematic review of psychosocial outcomes following education: self-management and psychological interventions in diabetes mellitus. Patient Educ. Couns. 51 (2003), 5–15.
28. [28] Hörnsten, Å., Stenlund, H., Lundman, B., Sandstrom, H., Improvements in HbA1c remain after 5 yearsöa follow up of an educational intervention focusing on patients—personal understandings of type 2 diabetes. Diabet. Res. Clin. Pract. 81 (2008), 50–55.
29. [29] Hörnsten, Å., Experiences of Diabetes Care—Patients’ and Nurses’ Perspectives [Medical Dissertation]. 2004, Umeå University, Umeå.
30. [30] Hernandez, C.A., Integration: the experience of living with insulin dependent (type 1) diabetes mellitus. Can. J. Nurs. Res. 28 (1996), 37–56.
31. [31] Hernandez, C.A., Antone, I., Cornelius, I., A grounded theory study of the experience of type 2 diabetes mellitus in first nations adults in Canada. J. Transcult. Nurs. 10 (1999), 220–228.
32. [32] Hörnsten, Å., Sandstrom, H., Lundman, B., Personal understandings of illness among people with type 2 diabetesv. J. Adv. Nurs. 47 (2004), 174–182.
33. [33] Hörnsten, Å., Lundman, B., Stenlund, H., Sandstrom, H., Metabolic improvement after intervention focusing on personal understanding in type 2 diabetes. Diabet. Res. Clin. Pract. 68 (2005), 65–74.
34. [34] Hörnsten, Å., Jutterström, L., Audulv, Å., Lundman, B., A model of integration of illness and self-management in type 2 diabetes. J. Nurs. Healthc. Chronic. Illn. 3 (2011), 41–51.
35. [35] Jutterström, L., Isaksson, U., Sandström, H., Hörnsten, Å., Turning points in self-management of type 2 diabetes. EDN 9 (2012), 46b–50b.
36. [36] John, W.G., Mosca, A., Weykamp, C., Goodall, I., HbA1c standardisation: history: science and politics. Clin. Biochem. Rev. 28 (2007), 163–168.
37. [37] Geistanger, A., Arends, S., Berding, C., Hoshino, T., Jeppsson, J.-O., Little, R., Siebelder, C., Weykamp, C., on behalf of the IFCC Working Group on HbA1c Standardization, Statistical methods for monitoring the relationship between the IFCC reference measurement procedure for hemoglobin a1c and the designated comparison methods in the United States, Japan, and Sweden. Clin. Chem. 54 (2008), 1379–1385.
38. [38] Wolf, F.M., Meta-analysis. Quantitative Methods for Research Synthesis. 1986, Sage, Beverly Hills, CA.
39. [39] Ovhed, I., Johansson, E., Odeberg, H., Råstam, L., A comparison of two different team models for treatment of diabetes mellitus in primary care. Scand. J. Caring Sci. 14 (2000), 253–258.
40. [40] Whittemore, R., Dixon, J., Chronic illness: the process of integration. J. Clin. Nurs. 17 (2008), 177–187.
41. [41] Steinsbekk, A., Rygg, L.Ø., Lisulo, M., Rise, M.B., Fretheim, A., Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis. BMC Health Serv. Res., 12, 2012, 213.
42. [42] Duke, S., Colagiuri, S., Colagiuri, R., Individual patient education for people with type 2 diabetes mellitus. Cochrane Database Syst Rev., 2009, 1.
43. [43] Swedish Council on Health Technology Assessment (SBU), Summary and Conclusions of the SBU Report: Patient Education in Managing Diabetes: a Systematic Review., 2009, Statens beredning för medicinsk utvärdering, Stockholm.
44. [44] Sperl-Hillen, J., Beaton, S., Fernandes, O., Von Worley, A., Vazquez-Benitez, G., Parker, E., Hanson, A., Lavin-Tompkins, J., Glasrud, P., Davis, H., Adams, K., Parsons, W., Spain, C.V., Comparative effectiveness of patient education methods for type 2 diabetes: a randomized controlled trial. Arch. Intern. Med. 171 (2011), 2001–2010.
45. [45] Adolfsson, E.T., Smide, B., Rosenblad, A., Wikblad, K., Does patient education facilitate diabetic patients’ possibilities to reach national treatment targets?. Scand. J. Prim. Health Care 27 (2009), 91–96.
46. [46] UK Prospective Diabetes Study Group, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352 (1998), 837–853.
47. [47] Del Prato, S., Barnett, A.H., Huisman, H., Neubacher, D., Woerle, H.-J., Dugi, K.A., Effect of linagliptin monotherapy om glycaemic control and markers of β-cell function in patients with inadequately controlled type 2 diabetes: a radomized controlled trial. Diabet. Obes. Metab. 13 (2011), 258–267.
48. [48] Raz, I., Hanefeld, M., Xy, L., Caria, C., Williams-Herman, D., Khatami Sitagliptin Study 023 Group, H., Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin as monotherapy in patients with type 2 diabetes mellitus. Diabetologia 49 (2006), 2564–2571, 10.1007/s00125-006-0416-z.
49. [49] Zoffman, V., Hörnsten, Å., Storbækken, S., Graue, M., Rasmussen, B., Wahl, A., Kirkevold, M., Translating person-centered care into practice: a comparative analysis of motivational interviewing, illness-integration support, and guided self-determination. Patient Educ. Couns. 99 (2016), 400–407, 10.1016/j.pec.2015.10.015.
50. [50] Schulz, K., Altman, D., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMC Med., 8, 2010, 18.